| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | SETX DDX31 SPAST TCP1 ATP13A1 DDX52 MYO19 SMCHD1 PEX6 ATP10A ORC1 MLH3 UBA6 ACIN1 ACSBG2 MTREX DYNC1H1 | 2.90e-06 | 614 | 147 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX31 SPAST TCP1 ATP13A1 DDX52 MYO19 SMCHD1 PEX6 ATP10A ORC1 MLH3 ACIN1 MTREX DYNC1H1 | 4.92e-06 | 441 | 147 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 DDX31 SPAST TCP1 ATP13A1 DDX52 MYO19 SMCHD1 PEX6 ATP10A EFTUD2 ORC1 MLH3 RGS6 ACIN1 MTREX DYNC1H1 | 1.52e-04 | 839 | 147 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 DDX31 SPAST TCP1 ATP13A1 DDX52 MYO19 SMCHD1 PEX6 ATP10A EFTUD2 ORC1 MLH3 RGS6 ACIN1 MTREX DYNC1H1 | 1.54e-04 | 840 | 147 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 DDX31 SPAST TCP1 ATP13A1 DDX52 MYO19 SMCHD1 PEX6 ATP10A EFTUD2 ORC1 MLH3 RGS6 ACIN1 MTREX DYNC1H1 | 1.54e-04 | 840 | 147 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX31 SPAST TCP1 ATP13A1 DDX52 MYO19 SMCHD1 PEX6 ATP10A EFTUD2 ORC1 MLH3 RGS6 ACIN1 MTREX DYNC1H1 | 1.94e-04 | 775 | 147 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 3.20e-04 | 4 | 147 | 2 | GO:0001010 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | MYCN CYP1B1 DMXL2 GARIN1A SETX WDR33 SMCHD1 SPEF2 ASH1L TSSK2 APOB DZIP1 NME8 SPATA31D4 FSIP2 SPATA31D3 NLRP14 MLH3 THRA THRB SBF1 BRCA2 ASPM ACSBG2 HERC2 | 7.56e-07 | 1194 | 144 | 25 | GO:0048609 |
| GeneOntologyBiologicalProcess | sexual reproduction | MYCN DMXL2 GARIN1A SETX CENPC TCP1 WDR33 SMCHD1 SPEF2 ASH1L TSSK2 APOB DZIP1 ADCY3 NME8 SPATA31D4 FSIP2 SPATA31D3 NLRP14 MLH3 SBF1 BRCA2 CCNE2 ASPM ACSBG2 HERC2 | 1.24e-06 | 1312 | 144 | 26 | GO:0019953 |
| GeneOntologyBiologicalProcess | male gamete generation | DMXL2 GARIN1A SETX WDR33 SPEF2 TSSK2 APOB DZIP1 NME8 SPATA31D4 FSIP2 SPATA31D3 NLRP14 MLH3 SBF1 BRCA2 ASPM ACSBG2 HERC2 | 1.54e-06 | 762 | 144 | 19 | GO:0048232 |
| GeneOntologyBiologicalProcess | spermatogenesis | DMXL2 GARIN1A SETX WDR33 SPEF2 TSSK2 APOB DZIP1 NME8 SPATA31D4 FSIP2 SPATA31D3 NLRP14 SBF1 BRCA2 ASPM ACSBG2 HERC2 | 4.52e-06 | 744 | 144 | 18 | GO:0007283 |
| GeneOntologyBiologicalProcess | gamete generation | MYCN DMXL2 GARIN1A SETX WDR33 SMCHD1 SPEF2 TSSK2 APOB DZIP1 NME8 SPATA31D4 FSIP2 SPATA31D3 NLRP14 MLH3 SBF1 BRCA2 ASPM ACSBG2 HERC2 | 4.70e-06 | 982 | 144 | 21 | GO:0007276 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | MYCN CYP1B1 DMXL2 GARIN1A SETX WDR33 SMCHD1 SPEF2 ASH1L TSSK2 APOB DZIP1 NME8 SPATA31D4 FSIP2 SPATA31D3 NLRP14 SBF1 BRCA2 ASPM ACSBG2 HERC2 | 4.66e-05 | 1235 | 144 | 22 | GO:0003006 |
| GeneOntologyBiologicalProcess | female courtship behavior | 1.45e-04 | 3 | 144 | 2 | GO:0008050 | |
| GeneOntologyBiologicalProcess | positive regulation of thyroid hormone receptor signaling pathway | 1.45e-04 | 3 | 144 | 2 | GO:0002157 | |
| GeneOntologyCellularComponent | nuclear body | SETD1A ZC3H14 SETX CENPC INPPL1 DZIP1 BOLA3 NME8 EFTUD2 PPP4R3B UBE2O THRB SBF1 SUGP2 ACIN1 PRPF19 MTREX MTDH | 6.04e-05 | 903 | 146 | 18 | GO:0016604 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SEH1L SETD1A SETX CENPC ACAT1 TCP1 MAP4K3 DDX52 MYO19 SMCHD1 RIOK3 HEATR1 ANKHD1 EFTUD2 ORC1 RIF1 SAFB SBF1 SUGP2 HNRNPUL2 ANLN LTN1 ASPM ACIN1 ANKRD17 PRPF19 PUM3 PRR14L HERC2 MTREX DYNC1H1 | 1.11e-14 | 1353 | 147 | 31 | 29467282 |
| Pubmed | SETD1A SETX SPAST SMCHD1 HECTD4 DZIP1 ANKHD1 TBC1D24 VANGL2 PPP4R3B UBE2O SBF1 ZNF532 ZNF592 ANKRD17 RPRD2 MTREX DAGLA IGSF3 | 1.28e-12 | 529 | 147 | 19 | 14621295 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SEH1L ZC3H14 TMA16 DDX31 AKAP8 CENPC ACAT1 TCP1 OGFR DDX52 SMCHD1 HEATR1 EFTUD2 ORC1 RIF1 SAFB SUGP2 ZNF592 ANLN ACIN1 PRPF19 PUM3 MTREX PCCB | 4.93e-12 | 989 | 147 | 24 | 36424410 |
| Pubmed | ZC3H14 DDX31 ACAT1 DDX52 SMCHD1 HEATR1 ANKHD1 RIF1 UBE2O SBF1 SUGP2 ACIN1 ANKRD17 PUM3 HERC2 MTREX DYNC1H1 | 2.85e-09 | 653 | 147 | 17 | 22586326 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SEH1L SETD1A DDX31 AKAP8 HECTD4 PPP4R3B SBF1 HNRNPUL2 ZNF592 ANKRD17 PUM3 RPRD2 HERC2 MTREX | 6.33e-09 | 440 | 147 | 14 | 34244565 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZC3H14 AKAP8 ACAT1 TCP1 DDX52 SMCHD1 HEATR1 EFTUD2 RIF1 SAFB SUGP2 HNRNPUL2 UBA6 ACIN1 PRPF19 PUM3 HERC2 MTREX MTDH DYNC1H1 | 1.38e-08 | 1024 | 147 | 20 | 24711643 |
| Pubmed | TMA16 SETX DDX31 AKAP8 TCP1 ATP13A1 WDR33 DDX52 SMCHD1 COBLL1 APOB ANKHD1 FMNL2 RIF1 SUGP2 ACIN1 ANKRD17 PRPF19 PUM3 HERC2 MTREX MTDH DYNC1H1 | 1.73e-08 | 1371 | 147 | 23 | 36244648 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZC3H14 DDX31 AKAP8 DDX52 SMCHD1 TRAIP HEATR1 RIF1 SUGP2 HNRNPUL2 ASPM ACIN1 PRPF19 PUM3 HERC2 MTREX MTDH | 2.59e-08 | 759 | 147 | 17 | 35915203 |
| Pubmed | ZC3H14 AKAP8 ACAT1 MPDZ EFTUD2 SAFB SUGP2 HNRNPUL2 ACIN1 MTREX MTDH | 2.73e-08 | 274 | 147 | 11 | 34244482 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SEH1L DMXL2 SORBS2 TMA16 SETX AKAP8 WDR33 HECTD4 GTF2IRD1 EFTUD2 VANGL2 SAFB SBF1 SUGP2 ZNF532 HNRNPUL2 ACIN1 PRPF19 MTDH DYNC1H1 | 3.41e-08 | 1082 | 147 | 20 | 38697112 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ZC3H14 DDX31 AKAP8 TCP1 WDR33 DDX52 HEATR1 ANKHD1 EFTUD2 UBE2O SAFB SUGP2 HNRNPUL2 ACIN1 PUM3 MTDH DYNC1H1 | 6.26e-08 | 807 | 147 | 17 | 22681889 |
| Pubmed | CYP1B1 ZC3H14 TMA16 SETX DDX31 AKAP8 GTPBP6 ATP13A1 DDX52 MPDZ HEATR1 ANKHD1 ORC1 RIF1 SBF1 ZNF592 ANLN LTN1 ANKRD17 PUM3 REEP4 HERC2 MTREX | 8.51e-08 | 1497 | 147 | 23 | 31527615 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 8.84e-08 | 130 | 147 | 8 | 35545047 | |
| Pubmed | SETD1A ZC3H14 TCP1 WDR33 SMCHD1 MPDZ HEATR1 ANKHD1 UBE2O SUGP2 ANLN ACIN1 RPRD2 DYNC1H1 | 9.90e-08 | 549 | 147 | 14 | 38280479 | |
| Pubmed | SEH1L ZC3H14 DDX31 AKAP8 DDX52 HEATR1 EFTUD2 RIF1 SAFB SUGP2 ZNF592 ACIN1 ANKRD17 PRPF19 PUM3 MTREX MTDH | 1.25e-07 | 847 | 147 | 17 | 35850772 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 SETX CENPC ACAT1 WDR33 SMCHD1 HEATR1 EFTUD2 RIF1 SAFB SUGP2 BRCA2 ANLN ACIN1 PRPF19 PUM3 RPRD2 MTDH | 1.29e-07 | 954 | 147 | 18 | 36373674 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SORBS2 SETX SPAST AKAP8 KIAA0232 INPPL1 COBLL1 TSSK2 MPDZ DZIP1 FSIP2 SBF1 ANLN ANKRD17 REEP4 MTREX FAM110B | 1.57e-07 | 861 | 147 | 17 | 36931259 |
| Pubmed | BIRC8 SETX MAP4K3 DDX52 ASH1L APOB HEATR1 ANKHD1 ADCY3 ZNF568 ANLN SBF2 LTN1 GRAMD2B ACIN1 ANKRD17 CEP295 TSTD2 MTDH | 1.75e-07 | 1084 | 147 | 19 | 11544199 | |
| Pubmed | 2.76e-07 | 102 | 147 | 7 | 9734811 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | AKAP8 TCP1 WDR33 DDX52 HEATR1 ANKHD1 NBAS SUGP2 ANLN PSMG1 LTN1 ANKRD17 PUM3 MTREX DYNC1H1 | 3.40e-07 | 704 | 147 | 15 | 29955894 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | ZC3H14 AKAP8 ACAT1 TCP1 DDX52 HEATR1 ANKHD1 EFTUD2 SAFB SUGP2 HNRNPUL2 PRPF19 PUM3 MTREX DYNC1H1 | 4.06e-07 | 714 | 147 | 15 | 28302793 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SEH1L ZC3H14 TMA16 SETX AKAP8 WDR33 DDX52 SMCHD1 HEATR1 GTF2IRD1 EFTUD2 ORC1 RIF1 SAFB ACIN1 PRPF19 RPRD2 REEP4 MTREX MTDH | 5.91e-07 | 1294 | 147 | 20 | 30804502 |
| Pubmed | SETD1A DDX31 AKAP8 TCP1 PHF23 WDR33 DDX52 SMCHD1 ANKHD1 RIF1 UBE2O SUGP2 HNRNPUL2 ZNF592 ANKRD17 PRPF19 PUM3 RPRD2 HERC2 PCCB DYNC1H1 | 6.79e-07 | 1429 | 147 | 21 | 35140242 | |
| Pubmed | 1.05e-06 | 244 | 147 | 9 | 29884807 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A GTPBP6 ATP13A1 INPPL1 HECTD4 PEX6 GTF2IRD1 ANKHD1 C2CD2 TBC1D24 ORC1 SBF1 SUGP2 ZNF592 SBF2 HERC2 DYNC1H1 IGSF3 | 1.08e-06 | 1105 | 147 | 18 | 35748872 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SEH1L SETX AKAP8 TCP1 WDR33 SMCHD1 EFTUD2 RIF1 ANLN ACIN1 PRPF19 MTREX DYNC1H1 | 1.27e-06 | 582 | 147 | 13 | 20467437 |
| Pubmed | SEH1L DMXL2 DDX31 AKAP8 CENPC ATP13A1 MPDZ EXT2 HEATR1 DZIP1 EFTUD2 VANGL2 NBAS UBE2O SBF1 ASPM UBA6 PRPF19 REEP4 HERC2 MTDH | 1.28e-06 | 1487 | 147 | 21 | 33957083 | |
| Pubmed | ZC3H14 CENPC ACAT1 TCP1 PHF23 SMCHD1 PPP4R3B RIF1 SAFB SUGP2 ZNF532 HNRNPUL2 ZNF592 PSMG1 UBA6 ACIN1 MTREX | 1.50e-06 | 1014 | 147 | 17 | 32416067 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ZC3H14 TMA16 AKAP8 TCP1 DDX52 SMCHD1 CD109 HEATR1 EFTUD2 SAFB HNRNPUL2 ANLN ACIN1 ANKRD17 PRPF19 PUM3 MTREX MTDH DYNC1H1 | 1.61e-06 | 1257 | 147 | 19 | 36526897 |
| Pubmed | AKAP8 CENPC DDX52 TFDP3 EFTUD2 SUGP2 ANLN PRPF19 RPRD2 MTREX | 1.98e-06 | 339 | 147 | 10 | 30415952 | |
| Pubmed | ZC3H14 TMA16 DDX31 AKAP8 WDR33 DDX52 EFTUD2 SAFB HNRNPUL2 LTN1 ACIN1 PRPF19 MTREX MTDH | 2.22e-06 | 713 | 147 | 14 | 29802200 | |
| Pubmed | DMXL2 SORBS2 SPAST GTPBP6 ATP13A1 ASH1L HECTD4 DZIP1 FMNL2 PPP4R3B UBE2O ZNF532 ZNF592 PSMG1 KCNJ6 HERC2 CADPS2 PCCB DYNC1H1 | 2.22e-06 | 1285 | 147 | 19 | 35914814 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 2.24e-06 | 89 | 147 | 6 | 22446626 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZC3H14 TCP1 SMCHD1 HEATR1 ANKHD1 EFTUD2 RIF1 UBE2O SAFB SUGP2 ACIN1 ANKRD17 PRPF19 RPRD2 PRR14L MTDH | 2.36e-06 | 934 | 147 | 16 | 33916271 |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | TCP1 DDX52 HEATR1 EFTUD2 SAFB SUGP2 HNRNPUL2 ACIN1 PRPF19 PUM3 MTDH | 2.39e-06 | 430 | 147 | 11 | 38172120 |
| Pubmed | The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. | 2.56e-06 | 7 | 147 | 3 | 16518401 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACAT1 TCP1 ATP13A1 DDX52 SMCHD1 APOB HEATR1 ANKHD1 EFTUD2 RIF1 UBE2O SAFB HNRNPUL2 UBA6 ACIN1 PRPF19 PUM3 MTREX MTDH DYNC1H1 | 2.58e-06 | 1425 | 147 | 20 | 30948266 |
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 4.98e-06 | 27 | 147 | 4 | 23395962 | |
| Pubmed | TMA16 ACAT1 TCP1 WDR33 DDX52 EFTUD2 SUGP2 HNRNPUL2 PRPF19 MTREX MTDH | 5.45e-06 | 469 | 147 | 11 | 37314180 | |
| Pubmed | 5.55e-06 | 104 | 147 | 6 | 9205841 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCN SORBS2 AKAP8 TBC1D2 GTF2IRD1 EFTUD2 RIF1 SAFB SUGP2 ZNF592 ANLN ACIN1 ANKRD17 PRG4 | 5.67e-06 | 774 | 147 | 14 | 15302935 |
| Pubmed | 6.20e-06 | 106 | 147 | 6 | 12429849 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | AKAP8 DDX52 EFTUD2 SAFB SUGP2 HNRNPUL2 ZNF592 ACIN1 PRPF19 PUM3 MTREX MTDH | 1.10e-05 | 605 | 147 | 12 | 28977666 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TMA16 SETX DDX31 CENPC SMCHD1 FSIP2 RIF1 UBE2O ZNF592 ANLN PUM3 HERC2 | 1.15e-05 | 608 | 147 | 12 | 36089195 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A DDX31 ACAT1 TCP1 DDX52 SMCHD1 HEATR1 EFTUD2 PPP4R3B SAFB HNRNPUL2 ACIN1 PRPF19 AMMECR1 MTREX PCCB MTDH DYNC1H1 | 1.23e-05 | 1318 | 147 | 18 | 30463901 |
| Pubmed | WDR33 DDX52 HEATR1 ADARB2 EFTUD2 SAFB SUGP2 HNRNPUL2 ACIN1 PRPF19 PUM3 MTREX MTDH | 1.48e-05 | 731 | 147 | 13 | 29298432 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.55e-05 | 259 | 147 | 8 | 30404004 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 1.60e-05 | 125 | 147 | 6 | 21654808 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEH1L AKAP8 SMCHD1 CD109 MPDZ EXT2 HEATR1 ANKHD1 VANGL2 UBE2O SBF1 HNRNPUL2 LTN1 ANKRD17 MTDH | 1.75e-05 | 974 | 147 | 15 | 28675297 |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11861164 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22570333 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 10430610 | ||
| Pubmed | Audiogenic seizure susceptibility in thyroid hormone receptor beta-deficient mice. | 1.77e-05 | 2 | 147 | 2 | 11496110 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26672044 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21622534 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 10346821 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 9861043 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 38889231 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11739587 | ||
| Pubmed | Impaired hair growth and wound healing in mice lacking thyroid hormone receptors. | 1.77e-05 | 2 | 147 | 2 | 25254665 | |
| Pubmed | Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism. | 1.77e-05 | 2 | 147 | 2 | 19282388 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20141582 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12750454 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 38757582 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28911178 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11222741 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 16781732 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17911173 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 10848522 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 1.77e-05 | 2 | 147 | 2 | 19415763 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15780976 | ||
| Pubmed | Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. | 1.77e-05 | 2 | 147 | 2 | 12933686 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24797634 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11726557 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 10691312 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18203951 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19853653 | ||
| Pubmed | New Insights into the Structure and Function of the Thyroid Hormone Receptor. | 1.77e-05 | 2 | 147 | 2 | 11725045 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20194731 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11113349 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18287507 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24325866 | ||
| Pubmed | Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. | 1.77e-05 | 2 | 147 | 2 | 12356724 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 9250685 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12198244 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12562961 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 2879243 | ||
| Pubmed | Distinct behavioral phenotypes in male mice lacking the thyroid hormone receptor α1 or β isoforms. | 1.77e-05 | 2 | 147 | 2 | 23567476 | |
| Pubmed | Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. | 1.77e-05 | 2 | 147 | 2 | 19549593 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 29753845 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 34718573 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15466465 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 10712278 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12776178 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24673558 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 37992217 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 23493375 | ||
| Pubmed | Regulation of neonatal Sertoli cell development by thyroid hormone receptor alpha1. | 1.77e-05 | 2 | 147 | 2 | 15858214 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20090848 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 9927422 | ||
| Interaction | SSRP1 interactions | MYCN ZC3H14 SETX AKAP8 NANOG EFTUD2 OVOL2 RIF1 UBE2O SAFB SBF1 SUGP2 BRCA2 HNRNPUL2 ZNF592 ANLN ACIN1 PRPF19 RPRD2 MTDH FMNL1 | 1.66e-08 | 685 | 143 | 21 | int:SSRP1 |
| Interaction | NUP43 interactions | SEH1L SETD1A SETX DDX31 SPAST CENPC TCP1 ASH1L CCDC168 HEATR1 ZNF518A FSIP2 RIF1 SAFB BRCA2 ZNF532 ZNF592 ACIN1 PCCB | 9.71e-08 | 625 | 143 | 19 | int:NUP43 |
| Interaction | SNRNP40 interactions | MYCN SETX DDX31 AKAP8 CENPC TCP1 DDX52 HEATR1 EFTUD2 SUGP2 BRCA2 ZNF532 HNRNPUL2 ANLN ACIN1 PRPF19 MTREX MTDH | 6.30e-07 | 637 | 143 | 18 | int:SNRNP40 |
| Interaction | RPS24 interactions | MYCN PRUNE2 DDX31 CENPC DDX52 RIOK3 CCDC168 HEATR1 EFTUD2 UBE2O ANLN PRPF19 PUM3 HERC2 MTDH DYNC1H1 | 1.15e-06 | 529 | 143 | 16 | int:RPS24 |
| Interaction | SIRT6 interactions | SEH1L SETD1A DDX31 AKAP8 TCP1 KIAA0232 HECTD4 EFTUD2 PPP4R3B SBF1 HNRNPUL2 ZNF592 ANKRD17 PUM3 RPRD2 HERC2 MTREX | 2.37e-06 | 628 | 143 | 17 | int:SIRT6 |
| Interaction | MEN1 interactions | SETD1A ZC3H14 DDX31 AKAP8 WDR33 DDX52 NANOG SMCHD1 HEATR1 EFTUD2 RIF1 SAFB SUGP2 BRCA2 ZNF592 ANLN ACIN1 ANKRD17 PRPF19 PUM3 MTREX MTDH | 3.51e-06 | 1029 | 143 | 22 | int:MEN1 |
| Interaction | SRRM1 interactions | MYCN ZC3H14 OGFR EFTUD2 UBE2O SAFB ANLN ACIN1 PRPF19 HERC2 MTDH DYNC1H1 | 7.29e-06 | 348 | 143 | 12 | int:SRRM1 |
| Interaction | TOP1 interactions | MYCN ZC3H14 AKAP8 WDR33 TRAIP EFTUD2 UBE2O SAFB BRCA2 HNRNPUL2 ANLN ACIN1 PRPF19 RPRD2 HERC2 MTREX MTDH | 9.22e-06 | 696 | 143 | 17 | int:TOP1 |
| Interaction | CIT interactions | ZC3H14 SORBS2 SETX DDX31 ACAT1 TCP1 SMCHD1 CD109 ASH1L APOB HEATR1 EFTUD2 NBAS RIF1 SAFB SUGP2 HNRNPUL2 ANLN ACIN1 PRPF19 PUM3 ACSBG2 PRR14L MTREX MTDH DYNC1H1 | 1.01e-05 | 1450 | 143 | 26 | int:CIT |
| Interaction | GLDC interactions | ZC3H14 AKAP8 ACAT1 MPDZ EFTUD2 SAFB SUGP2 HNRNPUL2 ACIN1 MTREX MTDH | 1.88e-05 | 321 | 143 | 11 | int:GLDC |
| Interaction | SIRT7 interactions | ZC3H14 DDX31 ACAT1 DDX52 SMCHD1 HEATR1 ANKHD1 RIF1 UBE2O SBF1 SUGP2 ACIN1 ANKRD17 PUM3 HERC2 MTREX DYNC1H1 | 2.17e-05 | 744 | 143 | 17 | int:SIRT7 |
| Interaction | CPSF6 interactions | MYCN ZC3H14 AKAP8 WDR33 TBC1D2 EFTUD2 SAFB SUGP2 HNRNPUL2 ANLN ACIN1 PRPF19 RPRD2 MTREX | 2.34e-05 | 526 | 143 | 14 | int:CPSF6 |
| Interaction | FGF11 interactions | 2.94e-05 | 170 | 143 | 8 | int:FGF11 | |
| Interaction | FRG1 interactions | 3.17e-05 | 85 | 143 | 6 | int:FRG1 | |
| Interaction | HDLBP interactions | TMA16 SPAST AKAP8 TCP1 ATP13A1 WDR33 SMCHD1 FMNL2 EFTUD2 RIF1 SUGP2 ANLN UBA6 PRPF19 HERC2 MTREX DYNC1H1 IGSF3 | 3.62e-05 | 855 | 143 | 18 | int:HDLBP |
| Interaction | MECP2 interactions | MYCN SEH1L DMXL2 SORBS2 TMA16 SETX DDX31 AKAP8 WDR33 HECTD4 GTF2IRD1 EFTUD2 VANGL2 SAFB SBF1 SUGP2 ZNF532 HNRNPUL2 ANLN ACIN1 PRPF19 MTDH DYNC1H1 | 3.73e-05 | 1287 | 143 | 23 | int:MECP2 |
| Interaction | ARGLU1 interactions | 3.77e-05 | 176 | 143 | 8 | int:ARGLU1 | |
| Interaction | CCND1 interactions | 3.85e-05 | 286 | 143 | 10 | int:CCND1 | |
| Interaction | SNRPA interactions | MYCN ZC3H14 AKAP8 WDR33 EFTUD2 SAFB HNRNPUL2 ANLN ACIN1 PRPF19 RPRD2 MTREX DYNC1H1 | 4.05e-05 | 482 | 143 | 13 | int:SNRPA |
| Interaction | RBM39 interactions | MYCN ZC3H14 AKAP8 ACAT1 TCP1 DDX52 HEATR1 ANKHD1 EFTUD2 UBE2O SAFB SUGP2 HNRNPUL2 ANLN ACIN1 PRPF19 PUM3 HERC2 MTREX DYNC1H1 | 4.77e-05 | 1042 | 143 | 20 | int:RBM39 |
| Interaction | KRT2 interactions | 4.86e-05 | 236 | 143 | 9 | int:KRT2 | |
| Interaction | LURAP1 interactions | 5.58e-05 | 137 | 143 | 7 | int:LURAP1 | |
| Interaction | TMA16 interactions | 5.94e-05 | 95 | 143 | 6 | int:TMA16 | |
| Interaction | SAP18 interactions | 6.60e-05 | 305 | 143 | 10 | int:SAP18 | |
| Interaction | RBBP7 interactions | TCP1 PHF23 NANOG TBC1D2 ASH1L ANKHD1 EFTUD2 UBE2O SAFB BRCA2 HNRNPUL2 ANLN PCCB | 6.77e-05 | 507 | 143 | 13 | int:RBBP7 |
| Interaction | OBSL1 interactions | PRUNE2 ZC3H14 TMA16 TCP1 DDX52 SMCHD1 HEATR1 EFTUD2 RIF1 SAFB SUGP2 HNRNPUL2 ACIN1 PRPF19 PUM3 HERC2 MTREX DYNC1H1 | 7.20e-05 | 902 | 143 | 18 | int:OBSL1 |
| Interaction | EED interactions | MYCN SETX CENPC TCP1 DDX52 NANOG MYO19 SMCHD1 HEATR1 EFTUD2 ORC1 RIF1 SAFB HNRNPUL2 ANLN LTN1 UBA6 ACIN1 PRPF19 PUM3 HERC2 MTREX PCCB DYNC1H1 | 7.90e-05 | 1445 | 143 | 24 | int:EED |
| Interaction | XRCC5 interactions | MYCN NANOG MPDZ EFTUD2 OVOL2 ORC1 SAFB THRA THRB BRCA2 ANLN FMNL1 DYNC1H1 | 7.93e-05 | 515 | 143 | 13 | int:XRCC5 |
| Interaction | TRIM28 interactions | MYCN SETD1A AKAP8 TCP1 WDR33 DDX52 NANOG HEATR1 ANKHD1 ZNF518A EFTUD2 PPP4R3B NBAS UBE2O SAFB SUGP2 BRCA2 ANLN PSMG1 LTN1 ANKRD17 PUM3 MTREX DYNC1H1 | 1.07e-04 | 1474 | 143 | 24 | int:TRIM28 |
| Interaction | MTREX interactions | 1.08e-04 | 262 | 143 | 9 | int:MTREX | |
| Interaction | CHD4 interactions | MYCN SETD1A AKAP8 DDX52 NANOG ANKHD1 EFTUD2 UBE2O SAFB SUGP2 BRCA2 HNRNPUL2 ZNF592 ACIN1 PRPF19 PUM3 MTREX MTDH | 1.18e-04 | 938 | 143 | 18 | int:CHD4 |
| Interaction | PRG4 interactions | 1.20e-04 | 14 | 143 | 3 | int:PRG4 | |
| Interaction | CDH5 interactions | 1.28e-04 | 109 | 143 | 6 | int:CDH5 | |
| Interaction | EFL1 interactions | 1.31e-04 | 69 | 143 | 5 | int:EFL1 | |
| Interaction | RNF2 interactions | MYCN ZC3H14 DDX31 AKAP8 OGFR DDX52 NANOG SMCHD1 HEATR1 EFTUD2 SUGP2 HNRNPUL2 ACIN1 PRPF19 PUM3 MTDH DYNC1H1 | 1.41e-04 | 866 | 143 | 17 | int:RNF2 |
| Interaction | SYF2 interactions | 1.50e-04 | 71 | 143 | 5 | int:SYF2 | |
| Interaction | TERF2IP interactions | SETD1A ZC3H14 SETX CENPC WDR33 OGFR SMCHD1 ORC1 RIF1 SUGP2 BRCA2 ZNF592 ANLN | 1.58e-04 | 552 | 143 | 13 | int:TERF2IP |
| Interaction | IFI16 interactions | SEH1L ZC3H14 TCP1 DDX52 SMCHD1 HEATR1 EFTUD2 SAFB ANLN ASPM ACIN1 PRPF19 PUM3 MTREX MTDH | 1.72e-04 | 714 | 143 | 15 | int:IFI16 |
| Interaction | MKRN1 interactions | 1.79e-04 | 165 | 143 | 7 | int:MKRN1 | |
| Interaction | NOB1 interactions | 1.80e-04 | 116 | 143 | 6 | int:NOB1 | |
| Interaction | TUBB4B interactions | MYCN SETX AKAP8 TCP1 NANOG INPPL1 ANKHD1 EFTUD2 UBE2O THRB ANLN HERC2 DYNC1H1 | 1.82e-04 | 560 | 143 | 13 | int:TUBB4B |
| Interaction | CCDC140 interactions | 1.88e-04 | 117 | 143 | 6 | int:CCDC140 | |
| Interaction | DOT1L interactions | MYCN SEH1L ZC3H14 DDX31 AKAP8 DDX52 NANOG HEATR1 EFTUD2 ORC1 RIF1 SAFB ZNF592 ACIN1 PUM3 MTREX | 2.00e-04 | 807 | 143 | 16 | int:DOT1L |
| Interaction | SIPA1 interactions | 2.01e-04 | 41 | 143 | 4 | int:SIPA1 | |
| Interaction | CBX3 interactions | MYCN SETD1A CENPC NANOG SMCHD1 COBLL1 HEATR1 GTF2IRD1 ZNF568 ZNF518A EFTUD2 RIF1 UBE2O ANLN | 2.08e-04 | 646 | 143 | 14 | int:CBX3 |
| Interaction | HECTD1 interactions | ZC3H14 DDX31 AKAP8 DDX52 SMCHD1 TRAIP HEATR1 EFTUD2 RIF1 SUGP2 HNRNPUL2 ASPM ACIN1 PRPF19 PUM3 HERC2 MTREX MTDH | 2.13e-04 | 984 | 143 | 18 | int:HECTD1 |
| Interaction | NLE1 interactions | 2.28e-04 | 228 | 143 | 8 | int:NLE1 | |
| Interaction | RNPS1 interactions | MYCN ZC3H14 CENPC WDR33 EFTUD2 UBE2O ANLN ACIN1 PRPF19 HERC2 MTREX | 2.30e-04 | 425 | 143 | 11 | int:RNPS1 |
| Interaction | CT45A5 interactions | 2.34e-04 | 78 | 143 | 5 | int:CT45A5 | |
| Interaction | UTP14A interactions | 2.42e-04 | 230 | 143 | 8 | int:UTP14A | |
| Interaction | MECOM interactions | AKAP8 TCP1 SMCHD1 DZIP1 NLRP14 HNRNPUL2 PRPF19 PUM3 MTREX DYNC1H1 | 2.44e-04 | 358 | 143 | 10 | int:MECOM |
| Interaction | PLEC interactions | MYO19 SPEF2 ASH1L TFDP3 EFTUD2 THRB BRCA2 ANLN HERC2 MTDH FMNL1 | 2.55e-04 | 430 | 143 | 11 | int:PLEC |
| Interaction | SMC5 interactions | ZC3H14 SETX CENPC ACAT1 WDR33 SMCHD1 HEATR1 EFTUD2 RIF1 SAFB SUGP2 BRCA2 ANLN ACIN1 PRPF19 PUM3 RPRD2 MTDH | 2.60e-04 | 1000 | 143 | 18 | int:SMC5 |
| Interaction | TOP3B interactions | MYCN SETD1A GTPBP6 ATP13A1 INPPL1 HECTD4 PEX6 APOB GTF2IRD1 ANKHD1 C2CD2 TBC1D24 ORC1 SAFB SBF1 SUGP2 ZNF592 SBF2 ACIN1 ANKRD17 HERC2 DYNC1H1 IGSF3 | 2.72e-04 | 1470 | 143 | 23 | int:TOP3B |
| Interaction | YWHAH interactions | ZC3H14 SORBS2 SETX SPAST AKAP8 KIAA0232 INPPL1 COBLL1 HECTD4 MPDZ DZIP1 EFTUD2 THRA SBF1 ANLN ANKRD17 REEP4 MTREX FAM110B | 2.98e-04 | 1102 | 143 | 19 | int:YWHAH |
| Interaction | ACIN1 interactions | 3.05e-04 | 301 | 143 | 9 | int:ACIN1 | |
| Interaction | MAP7 interactions | 3.13e-04 | 239 | 143 | 8 | int:MAP7 | |
| Interaction | FUS interactions | MYCN AKAP8 ACAT1 TCP1 WDR33 EFTUD2 SAFB THRA HNRNPUL2 ANLN ACIN1 PRPF19 RPRD2 MTREX DYNC1H1 | 3.22e-04 | 757 | 143 | 15 | int:FUS |
| Interaction | SNRPB interactions | MYCN ZC3H14 AKAP8 NANOG EFTUD2 SAFB HNRNPUL2 ANLN ACIN1 PRPF19 RPRD2 DYNC1H1 | 3.24e-04 | 517 | 143 | 12 | int:SNRPB |
| Interaction | THRAP3 interactions | MYCN ZC3H14 SPAST AKAP8 EFTUD2 OVOL2 UBE2O THRA BRCA2 ANLN ACIN1 | 3.28e-04 | 443 | 143 | 11 | int:THRAP3 |
| Interaction | CUL7 interactions | MYCN ZC3H14 ACAT1 TCP1 SMCHD1 APOB HEATR1 EFTUD2 RIF1 SAFB HNRNPUL2 ACIN1 PRPF19 MTREX MTDH DYNC1H1 | 3.35e-04 | 845 | 143 | 16 | int:CUL7 |
| Interaction | LUC7L interactions | 3.40e-04 | 242 | 143 | 8 | int:LUC7L | |
| Interaction | FXR1 interactions | MYCN AKAP8 NANOG ANKHD1 EFTUD2 SBF1 HNRNPUL2 ANLN UBA6 ANKRD17 GRIP2 HERC2 PCCB MTDH | 3.45e-04 | 679 | 143 | 14 | int:FXR1 |
| Interaction | THOC5 interactions | 3.47e-04 | 131 | 143 | 6 | int:THOC5 | |
| Interaction | PRPF19 interactions | MYCN SETD1A EFTUD2 PPP4R3B UBE2O ANLN LTN1 PKHD1 PRPF19 MTREX DYNC1H1 | 3.75e-04 | 450 | 143 | 11 | int:PRPF19 |
| Interaction | TRIM52 interactions | 3.76e-04 | 133 | 143 | 6 | int:TRIM52 | |
| Interaction | CDC5L interactions | MYCN SEH1L SETX AKAP8 CENPC TCP1 WDR33 SMCHD1 EFTUD2 ORC1 RIF1 HNRNPUL2 ANLN PRPF19 MTREX DYNC1H1 | 3.81e-04 | 855 | 143 | 16 | int:CDC5L |
| Interaction | THOC6 interactions | 3.88e-04 | 87 | 143 | 5 | int:THOC6 | |
| Interaction | ELAVL2 interactions | 3.95e-04 | 188 | 143 | 7 | int:ELAVL2 | |
| Interaction | DIMT1 interactions | 4.08e-04 | 189 | 143 | 7 | int:DIMT1 | |
| Interaction | PRPS2 interactions | 4.57e-04 | 253 | 143 | 8 | int:PRPS2 | |
| Interaction | ALB interactions | MYCN GARIN5B SETX DDX31 SPAST KIAA0232 APOB UBE2O ANLN DYNC1H1 | 4.88e-04 | 391 | 143 | 10 | int:ALB |
| Interaction | CLK2 interactions | 4.92e-04 | 195 | 143 | 7 | int:CLK2 | |
| Interaction | CATSPERB interactions | 4.93e-04 | 5 | 143 | 2 | int:CATSPERB | |
| Interaction | ZC3H18 interactions | MYCN ZC3H14 WDR33 DDX52 HEATR1 ADARB2 EFTUD2 SAFB SUGP2 HNRNPUL2 ANLN ACIN1 PRPF19 PUM3 MTREX MTDH | 5.03e-04 | 877 | 143 | 16 | int:ZC3H18 |
| Cytoband | 2p24-p23 | 1.02e-05 | 2 | 147 | 2 | 2p24-p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p24 | 1.39e-04 | 81 | 147 | 4 | chr2p24 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.97e-04 | 25 | 95 | 3 | 504 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SETX CENPC DDX52 MYO19 ZNF518A RIF1 SAFB BRCA2 PLXNC1 ANLN CCNE2 ASPM UBA6 ACIN1 | 1.50e-05 | 532 | 143 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DMXL2 SETX TCP1 SWT1 HEATR1 ATP10A ZNF518A ORC1 RIF1 BRCA2 ANLN CCNE2 PSMG1 UBA6 CEP295 AMMECR1 RNF182 | 3.85e-05 | 820 | 143 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | DMXL2 SETX TCP1 SWT1 NANOG HEATR1 ATP10A ZNF518A EFTUD2 ORC1 RIF1 BRCA2 ANLN PSMG1 PUM3 AMMECR1 RNF182 | 3.96e-05 | 822 | 143 | 17 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | CYP1B1 SETD1A SORBS2 COBLL1 ASH1L LYSMD3 TMEM132C ASPM CEP295 | 4.94e-05 | 249 | 143 | 9 | gudmap_developingGonad_P2_epididymis_1000_k3 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | TCP1 NANOG HEATR1 ATP10A ZNF518A ORC1 RIF1 BRCA2 ANLN PUM3 RNF182 | 6.44e-05 | 387 | 143 | 11 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3 | 7.15e-05 | 64 | 143 | 5 | GSM538398_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8.Sp.B16, 4- 8+ TCR+ 45+, B16 Melanoma Spleen, avg-3 | 8.30e-05 | 66 | 143 | 5 | GSM605770_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.90e-05 | 333 | 143 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | DMXL2 SETX TCP1 SWT1 NANOG HEATR1 ATP10A ZNF518A EFTUD2 ORC1 RIF1 BRCA2 ANLN PSMG1 PUM3 RNF182 | 9.32e-05 | 795 | 143 | 16 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 1.03e-04 | 69 | 143 | 5 | GSM538413_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 1.03e-04 | 69 | 143 | 5 | GSM538412_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | CYP1B1 SETD1A ASH1L LYSMD3 RIF1 PLXNC1 CCNE2 ASPM ACIN1 CEP295 RNF182 | 1.05e-04 | 409 | 143 | 11 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | COBLL1 ATP10A ORC1 BRCA2 ANLN CCNE2 GZMK CRTAM GRAMD2B ASPM CD96 | 1.08e-04 | 410 | 143 | 11 | GSM538387_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | MYCN CYP1B1 SETD1A WDR33 ASH1L ANKHD1 LYSMD3 RIF1 PLXNC1 CCNE2 ASPM ACIN1 ANKRD17 CEP295 RNF182 IGSF3 | 1.09e-04 | 806 | 143 | 16 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | 1.10e-04 | 70 | 143 | 5 | GSM605909_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | DMXL2 SETX TCP1 SWT1 NANOG HEATR1 ATP10A ZNF518A EFTUD2 ORC1 RIF1 BRCA2 ANLN PSMG1 PUM3 MTREX | 1.16e-04 | 810 | 143 | 16 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SORBS2 TMA16 HEATR1 GTF2IRD1 ANKHD1 ZNF518A ORC1 RIF1 SAFB NSG2 BRCA2 HNRNPUL2 PLXNC1 PTPRZ1 CCNE2 ASPM PUM3 CEP295 | 1.20e-04 | 989 | 143 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | CYP1B1 SETD1A SORBS2 COBLL1 ASH1L LYSMD3 TMEM132C ASPM CEP295 | 1.24e-04 | 281 | 143 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | DMXL2 SWT1 ASH1L GTF2IRD1 ANKHD1 FMNL2 ZNF518A RIF1 SAFB BRCA2 PLXNC1 PTPRZ1 CCNE2 ASPM CEP295 PRR14L | 1.55e-04 | 831 | 143 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | TMA16 SETX TCP1 NANOG HEATR1 ATP10A ZNF518A EFTUD2 ORC1 RIF1 BRCA2 ANLN PSMG1 PUM3 RNF182 | 2.58e-04 | 781 | 143 | 15 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 2.88e-04 | 385 | 143 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TMA16 SETX CENPC SWT1 SMCHD1 HEATR1 FMNL2 ORC1 PPP4R3B RIF1 BRCA2 ANLN PTPRZ1 CCNE2 ASPM UBA6 CEP295 MTREX HSD17B2 MTDH | 2.96e-04 | 1257 | 143 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | CYP1B1 SETD1A SORBS2 WDR33 COBLL1 ASH1L LYSMD3 MFAP3L TMEM132C RIF1 CCNE2 ASPM PKHD1 ACIN1 CEP295 | 3.20e-04 | 797 | 143 | 15 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | MYCN SETD1A TMA16 DDX31 SWT1 NANOG COBLL1 HEATR1 BOLA3 ZNF518A ORC1 RIF1 UBE2O BRCA2 PTPRZ1 CCNE2 UBA6 PUM3 AMMECR1 MTREX CADPS2 | 3.44e-04 | 1371 | 143 | 21 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | MYCN CYP1B1 SETD1A DMXL2 SMCHD1 ASH1L LYSMD3 RIF1 PLXNC1 CCNE2 ASPM ACIN1 ANKRD17 CEP295 RNF182 | 3.51e-04 | 804 | 143 | 15 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 3.74e-04 | 398 | 143 | 10 | GSM399397_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.79e-04 | 259 | 143 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | 4.37e-04 | 406 | 143 | 10 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 2.29e-08 | 200 | 147 | 9 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 2.29e-08 | 200 | 147 | 9 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.49e-07 | 152 | 147 | 7 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-06 | 160 | 147 | 7 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.99e-06 | 187 | 147 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 189 | 147 | 7 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-06 | 190 | 147 | 7 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 4.07e-06 | 196 | 147 | 7 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.07e-06 | 196 | 147 | 7 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 4.65e-06 | 200 | 147 | 7 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.65e-06 | 200 | 147 | 7 | 2afbb5b5742b956993796621fea7e0c9888754a1 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.65e-06 | 200 | 147 | 7 | 4462ebd5d4632788f10a93fadd2babae701c754f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.65e-06 | 200 | 147 | 7 | 0cb0755a101ec655359d051d6a8807408d727c55 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.14e-06 | 146 | 147 | 6 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 151 | 147 | 6 | ea62e92ccb984f44559b434f35c1c4450767c8f1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.24e-05 | 154 | 147 | 6 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 169 | 147 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 169 | 147 | 6 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-05 | 172 | 147 | 6 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-05 | 172 | 147 | 6 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.47e-05 | 174 | 147 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.55e-05 | 175 | 147 | 6 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | severe_influenza-Plasmablast|World / disease group, cell group and cell class (v2) | 2.55e-05 | 175 | 147 | 6 | e6d6c44510d5dc4eb0bae820125e42366f7a4e74 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-05 | 176 | 147 | 6 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-05 | 177 | 147 | 6 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-05 | 177 | 147 | 6 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 177 | 147 | 6 | 650095a17e1a39caea74a6e89646565b9332af5d | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 177 | 147 | 6 | d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.81e-05 | 178 | 147 | 6 | 86f1741636ed3e85bb4a65f84949b718fc38c290 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 180 | 147 | 6 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-05 | 180 | 147 | 6 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-05 | 180 | 147 | 6 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-05 | 183 | 147 | 6 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-05 | 183 | 147 | 6 | 3ebe334ad570e3525341badb558f369c61daf3d3 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.38e-05 | 184 | 147 | 6 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.38e-05 | 184 | 147 | 6 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 3.38e-05 | 184 | 147 | 6 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.38e-05 | 184 | 147 | 6 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.38e-05 | 184 | 147 | 6 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 184 | 147 | 6 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-05 | 186 | 147 | 6 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-05 | 186 | 147 | 6 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.59e-05 | 186 | 147 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 187 | 147 | 6 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-05 | 188 | 147 | 6 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.81e-05 | 188 | 147 | 6 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 188 | 147 | 6 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 189 | 147 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 189 | 147 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 191 | 147 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 191 | 147 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 191 | 147 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.29e-05 | 192 | 147 | 6 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 192 | 147 | 6 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.29e-05 | 192 | 147 | 6 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 192 | 147 | 6 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 192 | 147 | 6 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature|Fetal_brain / Sample Type, Dataset, Time_group, and Cell type. | 4.41e-05 | 193 | 147 | 6 | 1553c856f3b71c1b0a78ec8d59c7948144d9c5bb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 194 | 147 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 194 | 147 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 4.67e-05 | 195 | 147 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 4.95e-05 | 197 | 147 | 6 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 4.95e-05 | 197 | 147 | 6 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.95e-05 | 197 | 147 | 6 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.95e-05 | 197 | 147 | 6 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.95e-05 | 197 | 147 | 6 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 4.95e-05 | 197 | 147 | 6 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 5.09e-05 | 198 | 147 | 6 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.09e-05 | 198 | 147 | 6 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 5.09e-05 | 198 | 147 | 6 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.09e-05 | 198 | 147 | 6 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.09e-05 | 198 | 147 | 6 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.09e-05 | 198 | 147 | 6 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.09e-05 | 198 | 147 | 6 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 5.09e-05 | 198 | 147 | 6 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.09e-05 | 198 | 147 | 6 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-early_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.09e-05 | 198 | 147 | 6 | 36c848b747903ff875ebb241eefbcd889f39be29 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.23e-05 | 199 | 147 | 6 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.23e-05 | 199 | 147 | 6 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.23e-05 | 199 | 147 | 6 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.23e-05 | 199 | 147 | 6 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 5.23e-05 | 199 | 147 | 6 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.23e-05 | 199 | 147 | 6 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 5.23e-05 | 199 | 147 | 6 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.23e-05 | 199 | 147 | 6 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.23e-05 | 199 | 147 | 6 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.23e-05 | 199 | 147 | 6 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 5.23e-05 | 199 | 147 | 6 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.23e-05 | 199 | 147 | 6 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-05 | 199 | 147 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 5.23e-05 | 199 | 147 | 6 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.23e-05 | 199 | 147 | 6 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 5.23e-05 | 199 | 147 | 6 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 5.23e-05 | 199 | 147 | 6 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.38e-05 | 200 | 147 | 6 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 5.38e-05 | 200 | 147 | 6 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.38e-05 | 200 | 147 | 6 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | DDX31 AKAP8 OGFR DDX52 KIAA0232 INPPL1 MPDZ MFAP3L SAFB ZNF592 ACIN1 | 4.76e-08 | 195 | 144 | 11 | 6927_DN |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | CYP1B1 CACNB3 SPAST MPDZ GTF2IRD1 OVOL2 MLH3 CCNE2 PUM3 MTDH | 2.95e-07 | 185 | 144 | 10 | 7209_DN |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.59e-07 | 189 | 144 | 10 | 4716_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.82e-05 | 178 | 144 | 8 | 1112_DN | |
| Drug | AG-1478; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 2.59e-05 | 187 | 144 | 8 | 1141_DN | |
| Drug | NRB02976 | 3.30e-05 | 58 | 144 | 5 | CID005354459 | |
| Drug | Cyproterone acetate [427-51-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.49e-05 | 195 | 144 | 8 | 6124_UP | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 3144_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 4540_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 5290_DN | |
| Drug | Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 6218_DN | |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 5320_DN | |
| Drug | Levothyroxine | 3.97e-05 | 2 | 144 | 2 | DB00451 | |
| Drug | Liothyronine | 3.97e-05 | 2 | 144 | 2 | DB00279 | |
| Drug | Liotrix | 3.97e-05 | 2 | 144 | 2 | DB01583 | |
| Drug | 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid | 3.97e-05 | 2 | 144 | 2 | DB03176 | |
| Drug | KB 130015 | 3.97e-05 | 2 | 144 | 2 | ctd:C446946 | |
| Drug | Rafoxanide | 3.97e-05 | 2 | 144 | 2 | ctd:D011888 | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.04e-05 | 199 | 144 | 8 | 7192_DN | |
| Disease | thyroid hormone resistance syndrome (implicated_via_orthology) | 6.68e-05 | 3 | 140 | 2 | DOID:11633 (implicated_via_orthology) | |
| Disease | Generalized Thyroid Hormone Resistance | 1.33e-04 | 4 | 140 | 2 | C4722330 | |
| Disease | Dwarfism | 2.23e-04 | 25 | 140 | 3 | C0013336 | |
| Disease | Severe Congenital Microcephaly | 4.26e-04 | 31 | 140 | 3 | C3853041 | |
| Disease | free androgen index | 4.32e-04 | 374 | 140 | 8 | EFO_0007005 | |
| Disease | abnormal vaginal discharge smell | 4.62e-04 | 7 | 140 | 2 | EFO_0009408 | |
| Disease | Microlissencephaly | 5.14e-04 | 33 | 140 | 3 | C1956147 | |
| Disease | small cell lung carcinoma | 5.81e-04 | 80 | 140 | 4 | EFO_0000702 | |
| Disease | microcephaly (is_implicated_in) | 6.14e-04 | 8 | 140 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | gait measurement | 7.63e-04 | 150 | 140 | 5 | EFO_0007680 | |
| Disease | breast cancer | 7.87e-04 | 9 | 140 | 2 | MONDO_0007254 | |
| Disease | Charcot-Marie-Tooth disease | 1.05e-03 | 42 | 140 | 3 | cv:C0007959 | |
| Disease | triglycerides in large LDL measurement | 1.12e-03 | 43 | 140 | 3 | EFO_0022319 | |
| Disease | visual epilepsy (is_implicated_in) | 1.20e-03 | 11 | 140 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | colon cancer (implicated_via_orthology) | 1.20e-03 | 11 | 140 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Seizures, Focal | 1.55e-03 | 104 | 140 | 4 | C0751495 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 1.68e-03 | 13 | 140 | 2 | cv:C4082197 | |
| Disease | Duchenne muscular dystrophy, disease progression measurement | 1.74e-03 | 50 | 140 | 3 | EFO_0008336, MONDO_0010679 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.74e-03 | 50 | 140 | 3 | EFO_0022247 | |
| Disease | C-reactive protein measurement | CYP3A7 DMXL2 DDX52 COBLL1 TRAIP GPRC6A APOB CCDC168 ADCY3 RGS6 THRB KCNJ6 PCCB DAGLA | 1.83e-03 | 1206 | 140 | 14 | EFO_0004458 |
| Disease | triglycerides to total lipids in large LDL percentage | 1.84e-03 | 51 | 140 | 3 | EFO_0022331 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.84e-03 | 51 | 140 | 3 | EFO_0022240 | |
| Disease | Malignant neoplasm of breast | CYP1B1 SPAST AKAP8 TCP1 CD109 NME8 RIF1 NLRP14 BRCA2 ZNF532 HERC2 MTDH RNF182 | 1.85e-03 | 1074 | 140 | 13 | C0006142 |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.96e-03 | 14 | 140 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Colorectal Carcinoma | CYP1B1 CD109 APOB ADARB2 MLH3 PKHD1 ACIN1 MTDH RNF182 FAM110B | 1.96e-03 | 702 | 140 | 10 | C0009402 |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.96e-03 | 111 | 140 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | triglycerides in HDL measurement | 2.06e-03 | 53 | 140 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.06e-03 | 53 | 140 | 3 | EFO_0022286 | |
| Disease | waist-hip ratio | PRUNE2 DMXL2 NPR3 SMCHD1 COBLL1 TRAIP HECTD4 RIOK3 ADCY3 ZNF568 VANGL2 KCNJ6 SBF2 PCCB | 2.13e-03 | 1226 | 140 | 14 | EFO_0004343 |
| Disease | triglycerides in LDL measurement | 2.41e-03 | 56 | 140 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 2.41e-03 | 56 | 140 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.41e-03 | 56 | 140 | 3 | EFO_0022333 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 2.41e-03 | 56 | 140 | 3 | EFO_0022316 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.41e-03 | 56 | 140 | 3 | EFO_0022251 | |
| Disease | triglycerides in IDL measurement | 2.67e-03 | 58 | 140 | 3 | EFO_0022149 | |
| Disease | metabolic syndrome | 2.71e-03 | 200 | 140 | 5 | EFO_0000195 | |
| Disease | triglycerides in VLDL measurement | 2.80e-03 | 59 | 140 | 3 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.80e-03 | 59 | 140 | 3 | EFO_0022337 | |
| Disease | phospholipids in VLDL measurement | 2.80e-03 | 59 | 140 | 3 | EFO_0022301 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 2.80e-03 | 59 | 140 | 3 | EFO_0022260 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.94e-03 | 60 | 140 | 3 | EFO_0022330 | |
| Disease | total lipids in VLDL measurement | 2.94e-03 | 60 | 140 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.94e-03 | 60 | 140 | 3 | EFO_0022233 | |
| Disease | puberty onset measurement | 3.02e-03 | 125 | 140 | 4 | EFO_0005677 | |
| Disease | testosterone measurement | CYP3A7 COBLL1 TRAIP MCHR2 GTF2IRD1 C2CD2 SERPINB8 RGS6 THRB SBF2 CRTAM HSD17B2 PCCB FAM110B | 3.03e-03 | 1275 | 140 | 14 | EFO_0004908 |
| Disease | triglycerides in small VLDL measurement | 3.08e-03 | 61 | 140 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 3.08e-03 | 61 | 140 | 3 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 3.08e-03 | 61 | 140 | 3 | EFO_0022276 | |
| Disease | triglycerides in small HDL measurement | 3.22e-03 | 62 | 140 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 3.22e-03 | 62 | 140 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 3.22e-03 | 62 | 140 | 3 | EFO_0022322 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 3.22e-03 | 62 | 140 | 3 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 3.22e-03 | 62 | 140 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 3.22e-03 | 62 | 140 | 3 | EFO_0022299 | |
| Disease | sphingosine 1-phosphate measurement | 3.25e-03 | 18 | 140 | 2 | EFO_0800185 | |
| Disease | Disorder of organic acid metabolism | 3.25e-03 | 18 | 140 | 2 | cv:C1263739 | |
| Disease | triglycerides to total lipids in IDL percentage | 3.37e-03 | 63 | 140 | 3 | EFO_0022329 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 3.37e-03 | 63 | 140 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 3.37e-03 | 63 | 140 | 3 | EFO_0022292 | |
| Disease | Chronic myeloproliferative disorder | 3.63e-03 | 19 | 140 | 2 | C1292778 | |
| Disease | triglycerides in small LDL measurement | 3.68e-03 | 65 | 140 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 3.68e-03 | 65 | 140 | 3 | EFO_0021902 | |
| Disease | susceptibility to vaginal yeast infection measurement | 3.68e-03 | 65 | 140 | 3 | EFO_0008412 | |
| Disease | cholesterol in very large VLDL measurement | 3.68e-03 | 65 | 140 | 3 | EFO_0022230 | |
| Disease | total lipids in small VLDL | 4.01e-03 | 67 | 140 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 4.01e-03 | 67 | 140 | 3 | EFO_0022175 | |
| Disease | squamous cell carcinoma | 4.01e-03 | 67 | 140 | 3 | EFO_0000707 | |
| Disease | Microcephaly | 4.01e-03 | 67 | 140 | 3 | C0025958 | |
| Disease | triglycerides in very small VLDL measurement | 4.18e-03 | 68 | 140 | 3 | EFO_0022144 | |
| Disease | triglycerides to phosphoglycerides ratio | 4.18e-03 | 68 | 140 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 4.18e-03 | 68 | 140 | 3 | EFO_0022265 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 4.72e-03 | 71 | 140 | 3 | EFO_0022259 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRQDFSLVVSTKKVP | 481 | Q9ULK5 | |
| SLVVSTKKVPFFKLS | 486 | Q9ULK5 | |
| LPKSFKRKISVVSAT | 816 | Q9UKV3 | |
| VSTLKEVKPTVFIGV | 306 | Q5FVE4 | |
| KSSKKFDILVTTPNR | 281 | Q9Y2R4 | |
| IKKPTISTAVGLVTK | 271 | Q9NR48 | |
| AKTSLAPIIVFVKVS | 281 | P54284 | |
| ETLRFISTKLPDKTV | 416 | O43823 | |
| TLTKDEKVFPRSIKT | 601 | Q9HD20 | |
| TLEIKKFIPFSRVTS | 96 | P49863 | |
| KEKFPRATAIKVTDI | 41 | Q53S33 | |
| FVNVVKSTSPVKLKT | 331 | O96020 | |
| ALEVLSKIPKVTKTS | 1901 | Q8TDJ6 | |
| KEVVRRSKKVSVPST | 1721 | O75179 | |
| RSKKVSVPSTVISRV | 1726 | O75179 | |
| AKLKRVTIPSNTISV | 1096 | Q53SF7 | |
| LKKKTDLSIFRTPIS | 636 | Q8IZT6 | |
| TKVRVRFELKSPVKT | 591 | O60312 | |
| TVTLLRTVKPEFEKF | 321 | P17342 | |
| KRKDKVSILSTFLAP | 31 | Q9NS39 | |
| IRTVKSFLSKIPSVV | 46 | P49758 | |
| PKVTSRNFEKSITKL | 46 | Q15397 | |
| AKKSVFPKLSTVIRE | 336 | O94822 | |
| ITATIAKRKSFIGTP | 161 | Q8IVH8 | |
| AFEIAKRIPIITSAK | 201 | O75121 | |
| PLEFTKVKTFVSRII | 96 | O15232 | |
| SIKIPVKKFSSLTET | 106 | Q7Z3D4 | |
| VVSTKTPDRKLIFGK | 141 | O43824 | |
| VVRSFPIASITKEKK | 941 | Q86WG5 | |
| QSRAPVLTVVSKFKA | 586 | Q96H55 | |
| IGDKVRVKASVTTPK | 2641 | O95714 | |
| PSLKSRVTISVDKSK | 81 | A0A075B6R2 | |
| VKISQPKKRAETLVF | 191 | P48051 | |
| KSKAITPKRLLTSIT | 901 | Q9NQW6 | |
| PAKVAVTKTVASVLA | 11 | Q5CZC0 | |
| CPKIQIIRSSKEKTT | 506 | O60486 | |
| PSLKSSKVRTNVTVK | 811 | O60486 | |
| SRTLGEIPTLVFKKT | 771 | Q92628 | |
| EIPTLVFKKTSKLES | 776 | Q92628 | |
| FSKPIVRKKLSLSSQ | 736 | Q9UHC1 | |
| ITRKFKLEPSVSLVN | 886 | Q13608 | |
| KFRVPKIAEFTVTIL | 61 | Q9Y328 | |
| LFKTFSRKVVVVVPN | 551 | Q1KMD3 | |
| VPVKKQKTRTVFSST | 91 | Q9H9S0 | |
| APDFISKIKSRIVLV | 161 | Q8WVF5 | |
| SVSKVDKISRIIFPV | 451 | P34903 | |
| SPISKTFELISVIKE | 2196 | P23471 | |
| FLTKTAKFKEVIPIT | 241 | Q5MIZ7 | |
| TKQRPVARSKIKFTT | 96 | Q9BRP0 | |
| FLPAKKTSVKETQRT | 156 | Q9H8H2 | |
| KFTIDKVRKGLTVVT | 2326 | Q9Y4D8 | |
| KSVLDIVFSSITVPK | 66 | Q8NGJ1 | |
| FSPKAVTKLSVEARK | 1901 | A2RRP1 | |
| SFPVAALTKEKRISV | 956 | O95248 | |
| STATKITTIPNVKKI | 306 | Q5T6X5 | |
| EATVPKVTVITRKAY | 421 | P05166 | |
| TVLTTERKKRGKTVP | 181 | Q9UMS4 | |
| TVEAFKPILSTRSLK | 246 | O95456 | |
| RIKRKVAFSEITSPS | 261 | Q13415 | |
| VFTIIRSRKKTVPDI | 56 | Q969V1 | |
| SPDKKLTIFKTELRV | 4031 | P04114 | |
| KPKQEVKFRIVTLFS | 141 | Q6YHK3 | |
| PVTKLQVSKSKRTLT | 676 | O75054 | |
| SPRKKSTIIISGISK | 506 | Q9Y426 | |
| LVQTTKKTPSLTKRI | 91 | Q96P09 | |
| KKTPSLTKRISDTIF | 96 | Q96P09 | |
| IKKSIFRIRESPKET | 501 | P51587 | |
| STKEVKVIVLATPFK | 106 | O95727 | |
| FLETVKRKSESSPIV | 266 | Q03188 | |
| PKFRVITKIKTIGST | 966 | O60266 | |
| RPVVKVKLFTESTGV | 421 | Q86UW7 | |
| TVLKTVPFTARTAKR | 1056 | Q96PY5 | |
| RPKQEKAFSLKTIST | 481 | Q86UE4 | |
| VIKTVPFTARTGKRT | 1071 | O95466 | |
| KKVVISIRGTLSPKD | 391 | Q9Y4D2 | |
| SDIRKVTSVKPLKAI | 201 | Q8TC76 | |
| VKSNSLAFIKRTPVI | 111 | Q14204 | |
| SKPTEKTIFILFLVI | 171 | Q6PEY0 | |
| IKPKSFKVNVTLRES | 511 | Q16678 | |
| TIQITALEKITKPFF | 1101 | Q9H583 | |
| KRVTFALTTSTAKPK | 1351 | Q8NDH2 | |
| SPKASVSLIRKISKE | 5726 | Q8NDH2 | |
| FPRKVISFLTKSVKQ | 241 | P24462 | |
| TVCEKTITVPKGKRL | 66 | Q8N8Z6 | |
| ILAVADKIKFTVTRP | 766 | Q9UHL9 | |
| KSVITIDRIKPASVV | 271 | Q9C0E4 | |
| TKISIPAFSVTLIKK | 161 | Q96HH9 | |
| PAFSVTLIKKTKTAL | 166 | Q96HH9 | |
| VKEKPSISSSVSRLK | 2516 | Q9C0D2 | |
| TVEVTKTFLPLLRKS | 196 | P37059 | |
| VKDPSVSKSVERIFK | 111 | Q5VT52 | |
| ATKDVRIFTLKPVRK | 241 | Q96EE3 | |
| RIFTLKPVRKELTSS | 246 | Q96EE3 | |
| PVTAASTVDFLKIKK | 1116 | Q5THK1 | |
| VKKLIETFSPTESLR | 731 | A6NGG8 | |
| SLKVRTRKKTVPSDV | 241 | Q9H6H4 | |
| AKPLTLREVEVFKSS | 146 | Q9NZT2 | |
| KGLSITTKDPRIKFT | 176 | Q6NXP2 | |
| TKQITPYVRSIAKVK | 531 | Q6ZRF8 | |
| KELKVSRTVSPKSFA | 11 | Q9C093 | |
| ISPEEKFVITTTSRK | 66 | A6NHR9 | |
| VTRPFISSKFSSKIK | 3011 | Q8WUY3 | |
| RKKVKFTTFTTIPPD | 1051 | Q8N3T6 | |
| SIVKSEVFPVSKTLV | 536 | Q5UIP0 | |
| VPVKKQKTRTVFSST | 91 | Q6NSW7 | |
| IKDTSIPLKILKFSV | 576 | Q96PQ0 | |
| TRKAKTIPVQAFEVK | 301 | O15357 | |
| TVGVVDTRKKTKLIS | 1316 | Q7Z333 | |
| PTIVKVKSLKFATEA | 506 | P17987 | |
| LVRKSFKVHVPISII | 656 | Q6ZUB0 | |
| KPTLKEVVIVSATRT | 36 | P24752 | |
| FAVLPVTRKEKSTII | 3846 | P08F94 | |
| SKKVTLGVVFVSLVP | 206 | Q8N6D2 | |
| TESLKKIKRSVSPQT | 586 | Q9UBP0 | |
| KISFKIPIKSRDTLQ | 231 | Q5T5J6 | |
| TSTIKTKSSRLAKPV | 216 | Q8TBJ4 | |
| PKKRRKTVSFSAIEV | 1161 | O15047 | |
| QKAVSTDRTSVPKIK | 646 | Q86YF9 | |
| FKITTLKTTTLAPKV | 971 | Q92954 | |
| VPTRISEFEKLIQKS | 506 | O94875 | |
| SVVSFDKVKEPRKSR | 601 | Q15424 | |
| SEKLTKSKVQVFLPR | 256 | P50452 | |
| KAPITNEFRKTIKLT | 281 | Q9Y4X0 | |
| KEVVRRSKKLSVPAS | 1691 | Q8IWZ3 | |
| KVIPTECAIKVFKTT | 281 | O14730 | |
| TFVRDIAKTVSPEKL | 271 | Q9ULP9 | |
| PIVVFTETTEVRKTK | 931 | A0AVT1 | |
| LVRKSFKVHVPISII | 656 | P0C874 | |
| PAIPKVRIKTIKTSS | 356 | Q9HCE3 | |
| KKVAKIFPLSSDIVT | 156 | Q3ZCX4 | |
| ILRSSTTVKVFAKPE | 256 | P40200 | |
| SIAIIKPDAVISKKV | 156 | Q8N427 | |
| SIIKCAPSKVKIIFI | 1416 | O75970 | |
| EKQRVIFTSPIKALS | 181 | P42285 | |
| TKAVTTFTITVRPKN | 291 | P04198 | |
| AIPKVRIKTIKTSSG | 371 | Q92610 | |
| ITPAITRVVDFAKKL | 276 | P10828 | |
| STKKIPTVNRITPKT | 251 | Q8IX01 | |
| RVITEVSKVPSLSKL | 471 | Q93063 | |
| GVKPVLSTKSKFRVV | 281 | Q9C0C9 | |
| KTLPTKLRDALFTVV | 281 | Q8IZ13 | |
| AFALFVKTKEVPTKR | 56 | Q5T7W7 | |
| KPVSSVKERFVLKLT | 1411 | Q6AHZ1 | |
| PSDLRTIQTFVKKAK | 81 | Q9BUL5 | |
| VIHVPFIIISSSKKT | 251 | Q5H9I0 | |
| PRITISKKTKLVTLS | 36 | Q9UI54 | |
| IITPAITRVVDFAKK | 221 | P10827 | |
| VRTSTNKVKCPVFVV | 111 | Q9C0J8 | |
| LITQKRAVLTPFLTK | 96 | Q6AWC8 | |
| IFRPLKFNTTSVIKI | 576 | Q15029 | |
| FNVAVKIIDRKKTPT | 36 | Q96PF2 | |
| FRKRKLPVVSSVVKV | 291 | Q6PJT7 | |
| VTKKVVASPRIISLA | 326 | Q9P2T0 | |
| FEIKTPSRVITLKAA | 111 | Q9BYX2 | |
| AIPKTCKRKTIITVD | 166 | Q96EY4 | |
| RVKTVPSLFQAKLDT | 451 | Q9BWF2 | |
| TVVRKVSVTLKEIFT | 41 | Q9UJN7 | |
| SPFTVTKKESKDILI | 611 | Q8N5Q1 | |
| TVVFEKKILKTSLPT | 636 | Q86W24 |